Jan-Aug sales at BioMaxima up 88% as company enters Switzerland
11 years 12 weeks atpakaļ
PCZ’s drug wholesaling unit receives additional GIF permit
11 years 12 weeks atpakaļ
Bioton reports 23% rise in like-for-like sales in H1 thanks to strong insulin sales
11 years 12 weeks atpakaļ
Swissmed partners with AHP
11 years 12 weeks atpakaļ
Inno-Gene posts dynamic sales growth in Q2 as new ventures prepare to start operations
11 years 14 weeks atpakaļ
OTC market in CIS countries 2013
11 years 14 weeks atpakaļ
Ministry unveils new reimbursement lists
11 years 14 weeks atpakaļ
Ministry outlines changes to Reimbursement Act
11 years 16 weeks atpakaļ
Hebe to enter Katowice market
11 years 16 weeks atpakaļ
Biological and biosimilars drug market in Poland 2013
11 years 16 weeks atpakaļ
SUKL to apply new guidelines on examination of MA variations
11 years 16 weeks atpakaļ
Egis reports sales of €13.6m in Poland in April-June 2013
11 years 16 weeks atpakaļ
EI exits Magellan
11 years 16 weeks atpakaļ
ERROR: Tried to load source page, but remote server reported "503 Service Unavailable".
11 years 17 weeks atpakaļ
BioMaxima posts strong Q2 results, expects to complete new M&A deals in Q3
11 years 17 weeks atpakaļ
Private healthcare market in CIS countries 2013
11 years 17 weeks atpakaļ
Further increase in number of real users of Doz.pl in April 2013
11 years 18 weeks atpakaļ
Pharmena announces positive findings from 1-MNA supplement study
11 years 18 weeks atpakaļ
Swissmed to open talks with new investor as equity sale to LUX MED Group collapses
11 years 18 weeks atpakaļ
Dr. Max launches first drug under its brand name in the Czech Republic
11 years 18 weeks atpakaļ
- « pirmais
- ‹ iepriekšējais
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- …
- nākamais ›
- pēdējais »